[Corrigendum] Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance.
Oncol Rep 34: [Related article:] 1146–1152, 2015; DOI: 10.3892/or.2015.4074

After the publication of the article, the authors decided to add an Acknowledgements section:

Acknowledgments
Research activity leading to the results shown in the paper is the continuation of the IMI Predect program that received support from the Innovative Medicines initiative Joint Undertaking under grant agreement no. 115188, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007–2013) and EFPIA companies in kind contribution. Present results and conclusions are not endorsed by the Predect Consortium.
Biotechnology, Research and Development, Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., I-00040 Pomezia, Italy.
Loredana
L
Vesci
Tissue Macro Array Lab, University of Tor Vergata, I-00133 Rome, Italy.
Valeria
V
Carollo
Takis Biotechnology, Castel Romano, I-00128 Rome, Italy.
Giuseppe
G
Roscilli
Takis Biotechnology, Castel Romano, I-00128 Rome, Italy.
Luigi
L
Aurisicchio
Takis Biotechnology, Castel Romano, I-00128 Rome, Italy.
Fabiana Fosca
FF
Ferrara
Tissue Macro Array Lab, University of Tor Vergata, I-00133 Rome, Italy.
Luigi
L
Spagnoli
Biotechnology, Research and Development, Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., I-00040 Pomezia, Italy.
Rita
R
De Santis